These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17275962)

  • 21. Risk factors for Clostridium difficile toxin-positive nosocomial diarrhoea.
    Raveh D; Rabinowitz B; Breuer GS; Rudensky B; Yinnon AM
    Int J Antimicrob Agents; 2006 Sep; 28(3):231-7. PubMed ID: 16908119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutamate dehydrogenase as confirmatory test for Clostridium difficile toxin A/B-positive stools.
    Bignardi GE; Settle C
    J Hosp Infect; 2010 Aug; 75(4):327-8. PubMed ID: 20227790
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of two immunochromatographic tests (ImmunoCard Toxins A&B, Xpect C. difficile Toxin A&B) and PCR for the detection of Clostridium difficile toxins in faecal samples.
    Diederen BM; Verbakel H; Bergmans A; Peeters MF
    J Infect; 2007 Jun; 54(6):e251-2. PubMed ID: 17412423
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of two enzyme immunoassays for detection of Clostridium difficile toxins A and B in swine.
    Anderson MA; Songer JG
    Vet Microbiol; 2008 Apr; 128(1-2):204-6. PubMed ID: 18006252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of five commercial tests for the rapid diagnosis of Clostridium difficile-associated disease.
    Miendje Deyi VY; Vandenberg O; Mascart G; Gning S; Retore P; Douat N; Dediste A
    Clin Lab; 2008; 54(1-2):9-13. PubMed ID: 18510038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors].
    Tunçcan OG; Ulutan F; Karakuş R
    Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Profile of toxigenicity of Clostridium difficile strains isolated from paediatric patients with clinical diagnosis of antibiotic associated diarrhea (AAD)].
    Wultańska D; Pituch H; Obuch-Woszczatyński P; Meisel-Mikołajczyk F; Luczak M
    Med Dosw Mikrobiol; 2005; 57(4):377-82. PubMed ID: 16773831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of C. diff.-CUBE test for detection of Clostridium difficile-associated diarrhea.
    Kurzynski TA; Kimball JL; Schultz DA; Schell RF
    Diagn Microbiol Infect Dis; 1992 Aug; 15(6):493-8. PubMed ID: 1424501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clostridium difficile toxin A and other enteropathogens in stool specimens of children hospitalized due to acute diarrhoea].
    Rozkiewicz D; Zaremba ML; Fiedoruk K; Daniluk T; Sciepuk M; Kurzatkowska B; Sulik A; Ołdak E
    Przegl Epidemiol; 2005; 59(3):711-21. PubMed ID: 16433313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clostridium difficile infection.
    Stanley JD; Bartlett JG; Dart BW; Ashcraft JH
    Curr Probl Surg; 2013 Jul; 50(7):302-37. PubMed ID: 23764494
    [No Abstract]   [Full Text] [Related]  

  • 31. Discrepancies in testing recommendations for Clostridium difficile infection: updated review favors amplification test systems.
    Chapin K
    Expert Rev Mol Diagn; 2012 Apr; 12(3):223-6. PubMed ID: 22468811
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevalence of Clostridium difficile-associated diarrhoea among hospitalized Jordanian patients.
    Shehabi AA; Abu-Ragheb HA; Allaham NA
    East Mediterr Health J; 2001; 7(4-5):750-5. PubMed ID: 15332775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mortality of patients with antibiotic-associated diarrhoea: the impact of Clostridium difficile.
    Bishara J; Peled N; Pitlik S; Samra Z
    J Hosp Infect; 2008 Apr; 68(4):308-14. PubMed ID: 18353491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A large scale clinical evaluation of the AmpliVue and Illumigene molecular tests for the identification of Clostridium difficile-associated diarrhea in adult and pediatric patients.
    Antonara S; Daly J; Greene W; Leber A
    Diagn Microbiol Infect Dis; 2015 Aug; 82(4):265-8. PubMed ID: 26008122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of Clostridium difficile toxin: comparison of enzyme immunoassay results with results obtained by cytotoxicity assay.
    Musher DM; Manhas A; Jain P; Nuila F; Waqar A; Logan N; Marino B; Graviss EA
    J Clin Microbiol; 2007 Aug; 45(8):2737-9. PubMed ID: 17567791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential immunodetection of toxin B from highly virulent Clostridium difficile BI/NAP-1/027.
    Pollock NR; Song L; Zhao M; Duffy DC; Chen X; Sambol SP; Gerding DN; Kelly CP
    J Clin Microbiol; 2015 May; 53(5):1705-8. PubMed ID: 25716449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of Clostridium difficile infection in Polish pediatric patients with inflammatory bowel disease.
    Banaszkiewicz A; Wultanska D; Pituch H; Radzikowski A
    Inflamm Bowel Dis; 2010 Apr; 16(4):554. PubMed ID: 19705416
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevalence of enterotoxin producing Staphylococcus aureus in stools of patients with nosocomial diarrhea.
    Flemming K; Ackermann G
    Infection; 2007 Oct; 35(5):356-8. PubMed ID: 17721737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and infection control implications of Clostridium difficile infection with negative enzyme immunoassay for toxin.
    Guerrero DM; Chou C; Jury LA; Nerandzic MM; Cadnum JC; Donskey CJ
    Clin Infect Dis; 2011 Aug; 53(3):287-90. PubMed ID: 21765078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of Clostridium difficile toxins A and B.
    Murray-Leisure KA; Suguitan EA
    Am J Clin Pathol; 1987 Sep; 88(3):394. PubMed ID: 3115085
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.